Group 5/ 44 36 (81) -284% -321% 270 24 -91% Others 6/ (76) (72) (61) (113) (190) Profit attributable to owners of the Company 1,060 1,007 1,856 75% 84% 4,137 4,009 -3% Basic earnings per share (Baht) 0.77
+166% Share of profit (loss) from investments in JV (3) (4) +21% (14) (11) -26% Tax expenses (income) (34) 20 -277% (57) 61 -194% Profit (loss) attributable to equity holders of the parent (124) 78 -260
services (excluding fuel cost) 2,058.80 1,554.21 504.59 32.5 Revenue from finance lease contract 750.86 885.23 (134.37) (15.2) Share of profit of associates and joint ventures 1,081.13 888.83 192.30 21.6
global trade volume affected by trade tensions and the impact of structural changes in the Thai economy on export sector. Public expenditure and private investment would expand slower than the previous
of THB 712 mil. against THB 1,835 mil. when compared to end of 2017 as resulting from 1. THB 60 mil. increase in ordinary shares by Right Offering 2. THB 540 mil. increase in share premium of ordinary
share, amounting the total of Baht 256,500,000 as per the Sale of Shares Agreement of NU dated 13 July 2018, with the precedent condition that the Company as the seller must receive the approval from the
Bangkok Business Broadcasting Company Limited), a subsidiary in which the Company holds 149,900,002 ordinary shares with a par value of Baht 10 per share, equivalent to 99.9333 percent of total ordinary
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
subsidiaries -10.47 0.05 -10.52 -21040.00 Profit(Loss) attributable to equity holders of the company -71.46 -15.53 -55.93 -360.14 Basic Loss Per Share (Baht) -0.10 -0.04 Gross Margin -45.07% -2.21% Net Profit
(Decreased) % Assets Current assets Cash and cash equivalents 8.54 31.33 (22.79) (72.74) Trade and other current receivables 224.54 186.08 38.46 20.67 Contract assets 518.21 564.88 (46.67) (8.26) Inventories